Amy K. Wagner

TL;DR: Activity level after concussion affected symptoms and neurocognitive recovery, and athletes engaging in high levels of activity after concussion demonstrated worse neuroc cognitive performance.

TL;DR: Clinical and experimental research examining DAergic therapies after TBI is discussed, which will in turn elucidate the importance of DA for cognitive function/dysfunction after TBO as well as highlight the areas that require further study.

TL;DR: Multifaceted cellular, biochemical, and molecular monitoring of proteins and lipids is logical as an adjunct to guiding therapies and improving outcomes in traumatic and ischemic brain injury and appears to be on the verge of a breakthrough with the use of these markers as diagnostic, prognostic, and monitoring adjuncts, in neurointensive care.

TL;DR: It is hypothesized that TBI‐induced inflammation likely contributes to seizure development, and genetic variation in the interleukin‐1beta (IL‐1 β) gene, IL‐1β levels in cerebrospinal fluid and serum, and CSF/serum IL-1β ratios would predict PTE development post‐TBI.

TL;DR: The authors' subacute cytokine load score classifies individuals at risk for unfavorable outcomes following injury as higher proinflammatory burden with IL-6, relative to the anti-inflammatory marker IL-10, is significantly associated with outcome.